• Results
  • Access strategies: Context Part I: How do pharma companies ensure worldwide acce...
Access strategies: Context Part I

How do pharma companies ensure worldwide access to their products?

This part one of a four part series, describes how the Index assessed whether companies tailor their access strategies to reach patients across the income pyramid and how they overcome-specific access barriers.

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Back to top |